Blood Brain Barrier2022-06-03T14:29:21-05:00

Blood Brain Barrier Assay

Assess compound penetration quantitatively and changes to BBB permeability

Poor penetration of the Blood Brain Barrier is the cause for attrition for 95% of drugs developed for neurological disorders. Utilizing a novel BBB in vitro model, Visikol offers an in vitro assay capable of assessing the penetration kinetics of molecules passing across the BBB.

This assay service allows for both compound transport across the barrier to be studied as well as the effect of compounds on the structure and function of the BBB.